GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties
- PMID: 1324586
GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties
Abstract
GABAA-receptor subtypes in rat brain were characterized using anti-peptide antisera specific for the alpha 1-, alpha 3- and alpha 5-subunits. While a high abundance of alpha 1-containing receptors was demonstrated by immunoprecipitation (80-90% of receptors), the receptors precipitated with the alpha 3- and the alpha 5-antiserum were less frequent (18-25% and 10-23%, respectively). The three receptor populations displayed unique pharmacological properties as shown by radioligand binding. Diazepam, flumazenil and flunitrazepam displayed similar displacing potencies in [3H]-flumazenil binding. However, the affinities of CL 218872, beta CCM and zolpidem were up to 10-fold lower in the alpha 3- than the alpha 1-receptor population while intermediate values were found for the alpha 5-receptor population. In many brain areas, a neuron-specific expression of receptors containing either alpha 1- or alpha 3-subunits could be visualized immunohistochemically. It will be of major interest to determine, whether ligands with differential affinities for receptor subtypes in situ will provide novel therapeutic profiles.
Similar articles
-
Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.Mol Pharmacol. 1995 Oct;48(4):666-75. Mol Pharmacol. 1995. PMID: 7476892
-
Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.J Med Chem. 1996 Apr 26;39(9):1928-34. doi: 10.1021/jm950887n. J Med Chem. 1996. PMID: 8627617
-
GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits.J Comp Neurol. 1995 Aug 14;359(1):154-94. doi: 10.1002/cne.903590111. J Comp Neurol. 1995. PMID: 8557845
-
Biochemical, immunological, and pharmacological characterization of GABAA-benzodiazepine receptor subtypes.Adv Biochem Psychopharmacol. 1992;47:155-62. Adv Biochem Psychopharmacol. 1992. PMID: 1324569 Review. No abstract available.
-
GABAA receptor channels: from subunits to functional entities.Curr Opin Neurobiol. 1992 Jun;2(3):263-9. doi: 10.1016/0959-4388(92)90113-y. Curr Opin Neurobiol. 1992. PMID: 1379501 Review.
Cited by
-
Alterations in t-butylbicyclophosphorothionate binding in the brains of lidocaine-kindled rats.Metab Brain Dis. 1993 Dec;8(4):235-44. doi: 10.1007/BF01001064. Metab Brain Dis. 1993. PMID: 8190042
-
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.Parkinsons Dis. 2016;2016:2531812. doi: 10.1155/2016/2531812. Epub 2016 May 17. Parkinsons Dis. 2016. PMID: 27293955 Free PMC article. Review.
-
Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor.Br J Pharmacol. 1999 Sep;128(1):77-82. doi: 10.1038/sj.bjp.0702744. Br J Pharmacol. 1999. PMID: 10498837 Free PMC article.
-
Alcohol-induced tolerance and physical dependence in mice with ethanol insensitive alpha1 GABA A receptors.Alcohol Clin Exp Res. 2009 Feb;33(2):289-99. doi: 10.1111/j.1530-0277.2008.00832.x. Epub 2008 Nov 19. Alcohol Clin Exp Res. 2009. PMID: 19032579 Free PMC article.
-
In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.Sleep. 2010 Jul;33(7):859-60. doi: 10.1093/sleep/33.7.859. Sleep. 2010. PMID: 20614842 Free PMC article. No abstract available.